ANTI-POLLUTION 65
Designing a sustainable, silky, anti-pollution shield
Federica Carlomagno, Stefania Zanzottera – Roelmi HPC, Italy
Air pollution consistently ranks among the top risk factors for death and disability worldwide. Breathing polluted air has long been recognised as increasing a person’s chances of developing heart and chronic respiratory diseases, lung infections and cancer. In 2017, air pollution was the fifth highest mortality risk factor globally and was associated with about 4.9 million deaths and 147 million years of healthy life lost.1
The World Health Organization (WHO)
confirms that air pollution levels remain dangerously high in many countries of the world. New data from WHO show that 9 out of 10 people breathe air containing high levels of pollutants, estimating that around 7 million people die every year from exposure to polluted air. 91% of the world’s population lives in places where air quality exceeds WHO guideline limits.2 Apart from what we breathe, also our skin is constantly exposed to environmental pollution. Scientific studies have confirmed the tendency to the appearance of skin discomforts linked to the more polluted areas of the world. In addition, it has to be taken into consideration the effect of blue light coming from phones and TV / computer screens, and the fact that people are for the most of day in front of a screen. Since these rays can be harmful for the skin, it is necessary to protect it, the same as we commonly do with UV rays by using UV filters during sunbathing. In general, there is a growing attention, raising customers’ awareness. Cosmetic players are putting their efforts into developing efficient innovations to counteract the effect of pollution on skin, known as chronic inflammation, hyper pigmented complexion and faster ageing.
Research: a new active ingredient for anti-pollution
This industrial study aims to present a new natural shield that helps in slowing down the ageing process linked to skin exposition to agents such as urban dust or blue light from electronic devices. Roelmi HPC is an Italian producer of
February 2020 Abstract
Nano particles, heavy metals, UV rays and blue light are environmental factors that can stress the skin leading to a number of discomforts: chronic inflammation, hyper pigmented complexion and faster ageing. Moreover, the daily exposure to urban dust is a typical situation that can negative influence those processes. This article is designed to demonstrate the efficacy of a sustainable approach to skin protection against external agents.
100% 80% +20% 60%
40%
20%
0% Cell viability (%) CTR– CTR+ Plerasan Veil500 Figure 1: Cell viability evaluation.
active & functional ingredients for the Health & Personal Care markets, strictly committed to respecting nature and recreating natural properties within its cosmetic active ingredients. A biomimetic synergy of compounds has been developed to create a naturally strong shield for the skin. A perfect synergy of a unique vegetal sugar isolated from Pleurotus ostreatus mushroom and high molecular weight Sericin protein from a by- product of the silk production chain, was designed for extrinsic-induced ageing prevention. The upcoming active ingredient is named Plerasan® Beta-Glucan, Sericin).
Veil500 (INCI: Aqua,
The beta-glucan portion comes from the application of a patented soft extraction technology, which obtains a specific
chemical structure from the mushroom cell wall, a unique β-(1,3/1,6)-D-glucan, which acts as an immune response balancer and shows peculiar characteristics. It has a unique chemical structure:
Molecular mass: >750 kDa. It has been shown that bioactivity increases directly with molecular weight.3
Degree of branching: 0.25. Beta-glucans with a degree of branching between 0.20-0.33 are more active than the others.4
Conformation: 1,3 – 1,6. This chemical bond allows the formation of a helical over-structure5
permitting a better
interaction with skin immune system.3 1,6 side chains have the perfect length to interact with human cells.
Solubility: Not soluble in water, partial PERSONAL CARE EUROPE
% Viability
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92
